Compare Sinergi Inti Andalan Prima Tbk. (INET) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinergi Inti Andalan Prima Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Sinergi Inti Andalan Prima Tbk. trades at Rp226 (market cap 5.06T, 180.13M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 586.9K 24h volume). The key difference: Sinergi Inti Andalan Prima Tbk. is far larger — about 8× UBC Medical Indonesia Tbk.'s market cap, and Sinergi Inti Andalan Prima Tbk. is more actively traded (180.13M versus 586.9K). Which is the better fit depends on your goals.
| INET | LABS | |
|---|---|---|
Market Cap | 5.06T | 635.95B |
Volume | 180.13M | 586.9K |
Lot | 1.8M | 5.87K |
Turnover | 41.2B | 95.54M |
Average Price | 228.73 | 162.79 |
Value | 41.2B | 95.54M |
Indicative Equilibrium Price | 232 | 163 |
Indicative Equilibrium Volume | 23.71K | 16 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinergi Inti Andalan Prima Tbk.
PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.
Read more on INET →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
